Design, Synthesis, Characterization and Anticancer Evaluation of Novel Mixed Complexes Derived from 2-(1H-Benzimizadol-2-yl)aniline Schiff base and 2-Mercaptobenzimidazole or 2-Am - Egyptian Knowledge Bank

158582

Design, Synthesis, Characterization and Anticancer Evaluation of Novel Mixed Complexes Derived from 2-(1H-Benzimizadol-2-yl)aniline Schiff base and 2-Mercaptobenzimidazole or 2-Am

Article

Last updated: 01 Jan 2025

Overview Similar Items

Article

Design, Synthesis, DFT Studies and Anticancer Activity of Novel Metal Complexes Containing 1,3,5-triazino[1,2-a]benzimidazole Moiety Using Microwave as an Approach for Green Chemi

Article

Synthesis , Spectral Characterization And Anticancer Studies of Novel Azo Schiff Base And its Complexes with Ag(I),Au(lll) And Pt(lV) ions

Article

Synthesis and characterization of novel mixed complexes derived from 2-aminomethylbenzimidazole and 2-(1H-Benzimidazol-2-yl) aniline and theoretical prediction of toxicity

Article

Synthesis and characterization of new 1,2,4-triazole anticancer scaffold derivatives: In Vitro study

Article

Synthesis and physicochemical characterization of Schiff base complexes and examination of their selectivity index for breast and colon cancer cells.

Article

Design, Synthesis, and biological evaluation of a novel series of thiazole derivatives based on pyrazoline as anticancer agents

Article

Synthesis, Characterization and Antitumor Activity of Benzimidazole Phosphonate Derivatives

Article

Synthesis, Characterization and Anticancer Assessment of New Nitrogen- Cyclic Compounds

Article

Synthesis and Anticancer Activity Evaluation of New 1,2,4-Triazolyl-Quinazoline Hybrid Compounds and Their Pyrazolopyridine Analogs

Article

Design and Synthesis of Novel Pyrazoles, Pyrazolines, and Pyridines from Chalcone Derivatives with Evaluation of Their In Vitro Anticancer Activity Against T-47D and UACC-257 Cell